FirstWord Pharma – Freya Biosciences Announces Positive Topline Clinical Trial Results for FB101 in Women with Asymptomatic Vaginal Dysbiosis27 June 2023 View article https://freyabiosciences.com/wp-content/uploads/2026/02/Freya_Logo_Logo_Color.svg 0 0 themyscira https://freyabiosciences.com/wp-content/uploads/2026/02/Freya_Logo_Logo_Color.svg themyscira2023-06-27 12:00:332026-04-15 15:35:24FirstWord Pharma – Freya Biosciences Announces Positive Topline Clinical Trial Results for FB101 in Women with Asymptomatic Vaginal Dysbiosis
